arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Stryker Corporation

SYK Health Care Medical/Dental Instruments
$307.08
▲ +0.9% Today
as of Oct 22, 16:52 ET
Last 30 days +8.94% Sep 14 → Oct 22
$266.76 $277.59 $288.41 $299.24 $310.07 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$299.80
High
$309.67
Low
$299.36
Volume
$3M
Avg Vol
$2M
Mkt Cap
$105.6B
P/E (TTM)
56.34
Beta
—
52w High
$389.33
52w Low
$267.00
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

lean bull ▲ 4 ● 21 ▼ 0
Oct 21 · 14:40 Zacks neutral
PAHC or SYK: Which Is the Better Value Stock Right Now?
Oct 21 · 11:14 REGULATORY Zacks bullish
Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical Accuracy
Oct 20 · 11:49 Zacks neutral
The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services
▸ Show all 25 press releases & news Free account →

SYK earnings at a glance

Stryker Corporation (SYK) is scheduled to report earnings on Thursday, October 29, 2026 after the market closes — in 6 days. Analysts expect earnings per share of $3.60, compared with $3.19 in the same quarter last year (+13%). The options market is pricing a move of about ±3.8% after the report, a range of roughly $295.55 to $318.61 from today's $307.08. Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±4.3% on average; after the most recent report on Jul 30, 2026 it moved -6.4%. That means options currently expect about the same movement than SYK has typically delivered. SYK beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 32%. The share price of $307.08 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$267
$389
33% of range
Avg surprise (last 6)
+0.6%
Avg reaction (last 6)
-2.5%
33% positive
Latest IV / EM
32%
EM ±3.8% · $280 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$2.60$3.07$3.54$4.00$4.47 Actual $2.84Est $2.73Actual $3.13Est $3.06Actual $3.19Est $3.14Actual $4.47Est $4.40Actual $2.60Est $2.98Actual $3.69Est $3.46 Mar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$0$1.7B$3.5B$5.2B$6.9B Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 30, 2026Jun/2026 $3.69 $3.46 +6.7% +10.5% -6.4% earnings
Thu Apr 30, 20268K 2026-04-30 $2.60 $2.98 -12.8% — -6.5% earnings
Thu Jan 29, 20268K 2026-01-29 $4.47 $4.40 +1.6% — +4.3% earnings
Thu Oct 30, 2025Sep/2025 $3.19 $3.14 +1.6% — -3.5% earnings
Thu Jul 31, 2025Jun/2025 $3.13 $3.06 +2.3% — -3.8% earnings
Thu May 1, 2025Mar/2025 $2.84 $2.73 +4.0% — +1.1% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Oct 29, 2026Sep/2026AMC $3.60$3.19 +12.8%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$6.59B$6.02B——$6.02B$5.87B——
Cost of revenue$2.09B$2.21B—$2.21B$2.18B$2.12B—$1.98B
Gross profit$4.50B$3.81B——$3.84B$3.74B——
Operating income$1.66B$936M—$1.14B$1.11B$837M—$1.08B
Net income$1.28B$745M——$884M$654M——
EPS (diluted)$3.30$1.93——$2.29$1.69——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$3.39B$2.88B$4.01B$3.26B$2.38B$2.32B$3.65B$3.85B
Inventory$5.52B$5.42B$5.31B$5.37B$5.29B$5.11B$4.77B$5.29B
Total current assets$14.42B$13.34B$14.76B$13.71B$13.00B$13.02B$14.85B$14.67B
Total assets$47.93B$46.29B$47.84B$47.06B$46.33B$46.01B$42.97B$43.83B
Long-term debt$14.19B$14.22B$14.86B$14.85B$14.83B$14.38B$12.19B$13.32B
Total liabilities$23.94B$23.31B$25.42B$25.27B$25.14B$25.08B$22.34B$23.68B
Total equity$23.99B$22.98B$22.42B$21.79B$21.19B$20.93B—$20.15B

Implied volatility — last 90 days

25%33%41%49%57% Jun 07 — IV 35% · EM ±4.8%Jun 08 — IV 34% · EM ±4.5%Jun 09 — IV 34% · EM ±4.3%Jun 10 — IV 36% · EM ±4.2%Jun 11 — IV 35% · EM ±3.9%Jun 12 — IV 31% · EM ±3.2%Jun 15 — IV 33% · EM ±2.4%Jun 16 — IV 35% · EM ±2.1%Jun 17 — IV 47% · EM ±2.0%Jun 19 — IV 30% · EM ±6.5%Jun 22 — IV 30% · EM ±6.2%Jun 23 — IV 29% · EM ±6.0%Jun 24 — IV 30% · EM ±6.1%Jun 25 — IV 29% · EM ±5.6%Jun 26 — IV 29% · EM ±5.5%Jun 29 — IV 30% · EM ±5.3%Jun 30 — IV 31% · EM ±5.3%Jul 01 — IV 32% · EM ±5.3%Jul 02 — IV 32% · EM ±5.1%Jul 03 — IV 33% · EM ±5.1%Jul 06 — IV 34% · EM ±4.7%Jul 07 — IV 33% · EM ±4.3%Jul 08 — IV 32% · EM ±4.0%Jul 09 — IV 31% · EM ±3.7%Jul 10 — IV 29% · EM ±3.2%Jul 13 — IV 37% · EM ±3.1%Jul 14 — IV 42% · EM ±3.0%Jul 15 — IV 57% · EM ±3.4%Jul 16 — IV 54% · EM ±2.2%Jul 20 — IV 39% · EM ±9.2%Jul 21 — IV 39% · EM ±9.0%Jul 22 — IV 38% · EM ±8.6%Jul 23 — IV 38% · EM ±8.5%Jul 24 — IV 37% · EM ±8.2%Jul 27 — IV 39% · EM ±8.1%Jul 28 — IV 39% · EM ±7.9%Jul 29 — IV 40% · EM ±8.0%Jul 30 — IV 57% · EM ±11.2%Jul 31 — IV 32% · EM ±6.0%Aug 03 — IV 33% · EM ±5.9%Aug 04 — IV 37% · EM ±6.3%Aug 05 — IV 35% · EM ±5.8%Aug 06 — IV 34% · EM ±5.4%Aug 07 — IV 30% · EM ±4.6%Aug 10 — IV 33% · EM ±4.5%Aug 11 — IV 27% · EM ±3.5%Aug 12 — IV 30% · EM ±3.7%Aug 13 — IV 27% · EM ±3.2%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 29% · EM ±2.5%Aug 18 — IV 32% · EM ±2.3%Aug 19 — IV 31% · EM ±1.9%Aug 20 — IV 39% · EM ±1.6%Aug 24 — IV 27% · EM ±5.7%Aug 25 — IV 27% · EM ±5.6%Aug 26 — IV 29% · EM ±5.7%Aug 27 — IV 27% · EM ±5.3%Aug 28 — IV 25% · EM ±4.8%Aug 31 — IV 28% · EM ±5.0%Sep 01 — IV 27% · EM ±4.7%Sep 02 — IV 28% · EM ±4.8%Sep 03 — IV 27% · EM ±4.3%Sep 04 — IV 28% · EM ±4.4%Sep 07 — IV 31% · EM ±4.3%Sep 08 — IV 37% · EM ±4.8%Sep 09 — IV 34% · EM ±4.2%Sep 10 — IV 33% · EM ±4.0%Sep 11 — IV 35% · EM ±3.8%Sep 14 — IV 35% · EM ±2.9%Sep 15 — IV 41% · EM ±2.9%Sep 16 — IV 42% · EM ±2.5%Sep 17 — IV 35% · EM ±1.4%Sep 21 — IV 31% · EM ±6.5%Sep 22 — IV 31% · EM ±6.3%Sep 23 — IV 31% · EM ±6.2%Sep 24 — IV 30% · EM ±5.8%Sep 25 — IV 29% · EM ±5.5%Sep 28 — IV 30% · EM ±5.4%Sep 29 — IV 29% · EM ±5.0%Sep 30 — IV 30% · EM ±5.0%Oct 01 — IV 30% · EM ±4.9%Oct 02 — IV 30% · EM ±4.7%Oct 06 — IV 30% · EM ±4.0%Oct 07 — IV 35% · EM ±4.4%Oct 08 — IV 32% · EM ±3.8%

Sector peers

MMM
3M Company
$83.6B $175.56+2.5%
BSX
Boston Scientific Corporation
$60.3B $46.01+0.9%
BDX
Becton, Dickinson and Company
$49.1B $200.42+3.4%
MDLN
Medline Inc.
$46.6B $34.88-1.6%
DXCM
DexCom, Inc.
$31.8B $78.32-8.7%
RMD
ResMed Inc.
$31.8B $253.06+3.1%

SYK earnings FAQ

When is SYK's next earnings date?

Stryker Corporation is expected to report on October 29, 2026, after the market closes.

What is SYK's expected move for earnings?

Options currently price a move of about ±3.8%, or $11.53 per share either way from $307.08.

How does SYK stock usually react to earnings?

Across the last 6 reports the average next-day move was ±4.3%, up 2 times and down 4 times.

What EPS are analysts expecting from Stryker Corporation?

The consensus estimate is $3.60 per share, versus $3.19 a year ago.

What is SYK's implied volatility?

SYK's at-the-money implied volatility is about 32% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in